Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma in Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07258511
What this trial is testing

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 400
Testing effectiveness (Phase 2)UnknownNCT04891744
What this trial is testing

Selinexor in Combination With Thalidomide and Dexamethasone in RRMM

Who this might be right for
Multiple Myeloma
Li Zheng 48
Large-scale testing (Phase 3)Study completedNCT01311687
What this trial is testing

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

Who this might be right for
Multiple Myeloma
Celgene 455
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Not applicableUnknownNCT04143932
What this trial is testing

Multiple Myeloma Turkish Prospective Patient Registry

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Turkish Hematology Association 1,000
Large-scale testing (Phase 3)Ended earlyNCT04549363
What this trial is testing

Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Study completedNCT03413800
What this trial is testing

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Who this might be right for
Relapsed Hematologic MalignancyMultiple Myeloma
Ciusss de L'Est de l'Île de Montréal 10
Testing effectiveness (Phase 2)Ended earlyNCT01672736
What this trial is testing

A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 19
Very early researchUnknownNCT03559764
What this trial is testing

Study of BCMA CAR-T in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Allife Medical Science and Technology Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01794039
What this trial is testing

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 9
Testing effectiveness (Phase 2)Study completedNCT00087867
What this trial is testing

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Scios, Inc. 62
Not applicableUnknownNCT01859234
What this trial is testing

89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Medical Center Groningen 20
Testing effectiveness (Phase 2)Study completedNCT03548207
What this trial is testing

JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 126
Testing effectiveness (Phase 2)Looking for participantsNCT07096778
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 100
Large-scale testing (Phase 3)Study completedNCT03275285
What this trial is testing

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

Who this might be right for
Plasma Cell Myeloma
Sanofi 302
Early research (Phase 1)Ended earlyNCT02462525
What this trial is testing

Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 74
Not applicableNot Yet RecruitingNCT07713511
What this trial is testing

INfections in Patients Treated With CAR-T

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple MyelomaB-Cell Non-Hodgkin Lymphoma+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 290
Testing effectiveness (Phase 2)UnknownNCT04287855
What this trial is testing

Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Poitiers University Hospital 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850599
What this trial is testing

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
OHSU Knight Cancer Institute 5
Testing effectiveness (Phase 2)UnknownNCT04674514
What this trial is testing

APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ascentage Pharma Group Inc. 48
Next Page